Phase XIV, group 1 - 01.09.2020 - 30.08.2023
Ca.-No 194
Antibody-based approaches to activate NK in cancer immunotherapy
Israeli Partner: Angel Porgador, Ben-Gurion University
German Partner: Frank Momburg, DKFZ
Israeli Partner: Angel Porgador, Ben-Gurion University
German Partner: Frank Momburg, DKFZ